Medium materiality6/10
PTC Therapeutics price target raised to $109 from $106 at Wells Fargo
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
PTCT target raised to $109 by Wells Fargo; current price is $72.64. Price has drifted slightly lower since signal.
- PTCT target raised to $109 by Wells Fargo; price $72.64.
Key facts
- 01
Target: $109
- 02
Posted price: $72.64
- 03
Analyst firm: Wells Fargo
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.